Nektar Meets Failure Again, This Time In Phase II Lupus Study

 
• By Alaric DeArment
  
Nektar said the Phase II study of rezpeg in SLE failed • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D